LoginSubscribe Now
International In-house Counsel Journal Logo
International In-house Counsel Journal Logo
  • Home
  • Business Sectors
  • Areas of Law
  • Editorial Board
  • Write a Paper
  • Subscribe
  • Books
  • Reports
  • Back Issues
  • Terms and Conditions
  • Cookie Policy
  • Privacy Policy
  • PLS LogoCopyright & permissions
© 2026 International In-house Counsel Journal Ltd. | ISSN 1754-0607 | Picture Credits: Freepix, Unsplash and by permission of the authors
Back to library search

Client Centricity & the In-House Lawyer

January 2018ManagementPharmaceutical

Abstract

The practice of law has evolved, particularly given the advent of significant technological advances, enhancements, and the evolving nature of the business world. Twenty years ago, first year law students’ core curriculum involved legal writing and legal research, which was, in essence, how to use the law library to find cases, statutes, and law review articles in their corresponding shelved book and then “Sheperdize” the legal authorities to confirm case precedent and validity. Twenty to thirty years ago, major corporations and companies relied on outside counsel and law firms for their legal advice -- and did not have in-house attorneys beyond the General Counsel role. The change was an increasing awareness and recognition of the intrinsic value of in-house lawyers: here are legal experts that become embedded within the many facets and dimensions of the business, and, who can serve as a gatekeeper for the myriad of legal, ethical, and financial rules and obligations of the company. In-house lawyers serve an important role in advising and leading their client, “the company”. For instance, when an in-house attorney is involved in litigation or conducting an internal investigation, it is both ethically and professionally necessary to give the Upjohn warning -- clearly identifying the communications between the company counsel and employees as privileged – but that privilege belongs to the company as client, not the individual employees.

Subscribe to reador
PLS Logo Copyright & permissions

Author

Kari Loeser

Senior Counsel, Jazz Pharmaceuticals , USA

Related Papers

Managing Compliance Risk in a COVID and Post-COVID World
Managing risk can be complicated in the best of times, and the challenges associated with risk management become even greater when combined with the tremendous disruption caused by a global...Read more
Portrait image of Fabiana Lacerca-Allen
Fabiana Lacerca-Allen
Chief Compliance Officer, Cipla, USA
Portrait image of Tatiyana Akers
Tatiyana Akers
Associate Director, Compliance, Aimmune Therapeutics, USA
Portrait image of Laura Hamm
Laura Hamm
Sr. Director, Corporate Compliance, Aimmune Therapeutics, USA
Portrait image of Brenda Crabtree
Brenda Crabtree
Director, Compliance Auditing and Monitoring, Aimmune Therapeutics, USA
Paper Title International Pharma Congresses during Covid-19
Pharmaceutical congresses and conferences are one of the preferred resources for doctors to learn about new research, treatments and indications . Such congresses in 2020 have become ‘virtual’ in response...
Read more
Portrait image of Geraldine Benjamin
Geraldine Benjamin
English Solicitor, Bailhache Labesse Trustees, UK
Making it Stick: How to Provide Legal Advice that Influences Business Decisions
As attorneys, determining the most risk-averse legal advice to give to our business partners often comes naturally. After all, we have both academic and professional experience in considering legal questions. But...Read more
Portrait image of Joshua Axelrod
Joshua Axelrod
Brand Counsel, Celgene Corporation, Ireland
A Glance at Some of the Challenges of the GC Role in Pharma
In the heavily regulated environment in which pharmaceutical companies operate, success is defined by ensuring corporate compliance with disparate laws and regulations without fettering the creativity and innovation on which...Read more
Portrait image of Galit Gonen
Galit Gonen
Senior Vice President & General Counsel for Teva Europe, Teva Pharmaceuticals, UK